News
-
Clinical News
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc. announced that it has submitted a New Drug Application (NDA) for Mitapivat to the U.S. Food and…
Read More » -
Clinical News
TIF Is Actively Participating In The 26th EHA Annual Congress
TIF is excited to be participating in the 26th EHA Annual Congress, held this year virtually on 09 – 17…
Read More » -
NOVITÀ
TIF Proudly Supports World Blood Donor Day 2021
June 14 marks World Blood Donor Day 2021. World Blood Donor Day (WBDD) is a very special occasion dedicated to…
Read More » -
Clinical News
Bluebirdbio Announces The Lifting Of FDA Clinical Hold for Sickle Cell Disease And β-Thalassaemia Studies
bluebird bio, Inc. today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical holds on the…
Read More » -
TIF News (IT)
TIF e-Academy: Reimagining Thalassaemia and Sickle Cell Disease Education
Read. Learn. Empower. The Thalassaemia International Federation´s internationally acclaimed Educational Programme is a fundamental component of TIF´s work and is…
Read More » -
Clinical News
US STUDY: COVID-19 Does Not Pose A Threat To Blood And Transfusion Safety
A new reassuring US study, published recently in the journal Transfusion, suggests that the risk of transmission of SARS-CoV2 through…
Read More » -
Clinical News
Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization
The World Health Organization (WHO) announced yesterday that it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency…
Read More » -
NOVITÀ
-
NOVITÀ
TIF Declares Support For Patent Waiver On COVID-19 Vaccines
In the midst of the raging COVID-19 pandemic, US President Joe Biden openly supported the World Trade Organization’s (WTO) proposal…
Read More »